MENU
+Compare
NVCR
Stock ticker: NASDAQ
AS OF
Dec 26 closing price
Price
$13.48
Change
+$0.04 (+0.30%)
Capitalization
1.51B

NVCR NovoCure Limited Forecast, Technical & Fundamental Analysis

NovoCure Ltd is an oncology company with a propreitary platform technology in United States... Show more

NVCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NVCR with price predictions
Dec 26, 2025

NVCR in upward trend: 10-day moving average broke above 50-day moving average on December 17, 2025

The 10-day moving average for NVCR crossed bullishly above the 50-day moving average on December 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NVCR just turned positive on November 21, 2025. Looking at past instances where NVCR's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

NVCR moved above its 50-day moving average on December 19, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVCR advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 117 cases where NVCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where NVCR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on December 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVCR as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NVCR broke above its upper Bollinger Band on November 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NVCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.423) is normal, around the industry mean (63.836). P/E Ratio (0.000) is within average values for comparable stocks, (37.256). NVCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.634). NVCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (2.320) is also within normal values, averaging (37.337).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NVCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVCR is expected to report earnings to rise 21.67% to -40 cents per share on February 19

NovoCure Limited NVCR Stock Earnings Reports
Q4'25
Est.
$-0.40
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.25
The last earnings report on October 30 showed earnings per share of -33 cents, beating the estimate of -41 cents. With 658.86K shares outstanding, the current market capitalization sits at 1.51B.
A.I. Advisor
published General Information

General Information

a commercial-stage oncology company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWAZX41.600.11
+0.27%
Hotchkis & Wiley Value Opps Z
MTCCX40.480.09
+0.22%
MFS Technology C
NGJIX19.340.02
+0.10%
Nuveen Global Real Estate Securities I
NSCFX52.99-0.08
-0.15%
Nuveen Small-Cap Value Opps R6
FTHNX50.73-0.09
-0.18%
FullerThaler Behavioral Sm-Cp Eq Inv

NVCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with QDEL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+0.30%
QDEL - NVCR
43%
Loosely correlated
+1.35%
ENOV - NVCR
42%
Loosely correlated
+1.97%
BFLY - NVCR
40%
Loosely correlated
-2.53%
OFIX - NVCR
40%
Loosely correlated
+0.53%
INMD - NVCR
40%
Loosely correlated
+1.04%
More

Groups containing NVCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+0.30%
Medical/Nursing Services
industry (213 stocks)
47%
Loosely correlated
-0.28%
Health Services
industry (403 stocks)
2%
Poorly correlated
-0.17%